Crossmark

Early antibody therapy can induce long-lasting immunity to SHIV

Crossref DOI link: https://doi.org/10.1038/nature21435

Published Online: 2017-03-13

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nishimura, Yoshiaki

Gautam, Rajeev

Chun, Tae-Wook

Sadjadpour, Reza

Foulds, Kathryn E.

Shingai, Masashi

Klein, Florian

Gazumyan, Anna

Golijanin, Jovana

Donaldson, Mitzi

Donau, Olivia K.

Plishka, Ronald J.

Buckler-White, Alicia

Seaman, Michael S.

Lifson, Jeffrey D.

Koup, Richard A.

Fauci, Anthony S.

Nussenzweig, Michel C.

Martin, Malcolm A.
License Information

Text and Data Mining valid from 2017-03-01
More Information

Article History

Received: 31 August 2016

Accepted: 27 January 2017

First Online: 13 March 2017

Competing interests

: The authors declare no competing financial interests.